 |
|
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
Suh Yoon Yang, Hyun Woong Lee, Youn Jae Lee, Sung Jae Park, Ki Young Yoo, Hyung Joon Kim
Clin Mol Hepatol. 2015;21(2):125-130. Published online 2015 Jun 26 DOI: https://doi.org/10.3350/cmh.2015.21.2.125
|
|
Citations to this article as recorded by
 Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia
In Jung Kim, Sung Hwan Yoo, Sora Kim, Young Youn Cho, Ki Young Yoo, Hyung Joon Kim, Hyun Woong Lee
Journal of Clinical Medicine.2022; 11(5): 1451. CrossRef Viral hepatitis in haemophilia: historical perspective and current management
Cas J. Isfordink, Karel J. van Erpecum, Marc van der Valk, Evelien P. Mauser‐Bunschoten, Michael Makris
British Journal of Haematology.2021; 195(2): 174. CrossRef Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced
Hyun Woong Lee, Ki Young Yoo, Joung Won Won, Hyung Joon Kim
Gut and Liver.2017; 11(5): 721. CrossRef KASL clinical practice guidelines: management of hepatitis C
Clinical and Molecular Hepatology.2016; 22(1): 76. CrossRef
|